Th17 cells: From precursors to players in inflammation and infection

International Immunology

Volumn 21, Issue 5, 2009, Pages 489-498

  Awasthi, Amit ^a   Kuchroo, Vijay K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Cytokines; Infection; Regulatory T cells; Th subsets

Indexed keywords

CYTOKINE; INTERLEUKIN 17; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; CELL EXPANSION; CELL MATURATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; EFFECTOR CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; PARASITOSIS; PRE T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; CELL DIFFERENTIATION; HELPER CELL; IMMUNOLOGY; INFECTION; METABOLISM;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CYTOKINES; HUMANS; INFECTION; INFLAMMATION; INTERLEUKIN-17; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 65549152333     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp021     Document Type: Review

References (110)

1. Reiner, S. L. 2007. Development in motion: Helper T cells at work. Cell 129:33.
2. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. and Coffman, R. L. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
3. Mosmann, T. R. and Coffman, R. L. 1989. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
4. Kaplan, M. H., Sun, Y. L., Hoey, T. and Grusby, M. J. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174.
5. Meraz, M. A., White, J. M., Sheehan, K. C. et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431.
6. Kaplan, M. H., Schindler, U., Smiley, S. T. and Grusby, M. J. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313.
7. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G. and Glimcher, L. H. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655.
8. Zheng, W. and Flavell, R. A. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587.
9. Oppmann, B., Lesley, R., Blom, B. et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715.
10. Ferber, I. A., Brocke, S., Taylor-Edwards, C. et al. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5.
11. Bettelli, E., Korn, T., Oukka, M. and Kuchroo, V. K. 2008. Induction and effector functions of T(H)17 cells. Nature 453:1051.
12. Kuchroo, V. K., Anderson, A. C., Waldner, H., Munder, M., Bettelli, E. and Nicholson, L. B. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): Role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20:101.
13. Das, M. P., Nicholson, L. B., Greer, J. M. and Kuchroo, V. K. 1997. Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein. J. Exp. Med. 186:867.
14. McGeachy, M. J. and Cua, D. J. 2008. Th17 cell differentiation: The long and winding road. Immunity 28:445.
15. Parham, C., Chirica, M., Timans, J. et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168:5699.
16. Wiekowski, M. T., Leach, M. W., Evans, E. W. et al. 2001. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166:7563.
17. Cua, D. J., Sherlock, J., Chen, Y. et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744.
18. Gran, B., Zhang, G. X., Yu, S. et al. 2002. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169:7104.
19. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910.
20. Kotake, S., Udagawa, N., Takahashi, N. et al. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103:1345.
21. Lock, C., Hermans, G., Pedotti, R. et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:500.
22. Murphy, C. A., Langrish, C. L., Chen, Y. et al. 2003. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951.
23. Langrish, C. L., Chen, Y., Blumenschein, W. M. et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233.
24. Rouvier, E., Luciani, M. F., Mattei, M. G., Denizot, F. and Golstein, P. 1993. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150:5445.
25. Maitra, A., Shen, F., Hanel, W. et al. 2007. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc. Natl Acad. Sci. USA 104:7506.
26. Hwang, S. Y., Kim, J. Y., Kim, K. W. et al. 2004. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Res. Ther. 6:R120.
27. Moseley, T. A., Haudenschild, D. R., Rose, L. and Reddi, A. H. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155.
28. Kolls, J. K. and Linden, A. 2004. Interleukin-17 family members and inflammation. Immunity 21:467.
29. Bettelli, E., Carrier, Y., Gao, W. et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235.
30. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179.
31. Mangan, P. R., Harrington, L. E., O'Quinn, D. B. et al. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231.
32. Li, M. O. and Flavell, R. A. 2008. TGF-beta: A master of all T cell trades. Cell 134:392.
33. Shull, M. M., Ormsby, I., Kier, A. B. et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693.
34. Kulkarni, A. B., Huh, C. G., Becker, D. et al. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl Acad. Sci. USA 90:770.
35. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
36. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330.
37. Marie, J. C., Letterio, J. J., Gavin, M. and Rudensky, A. Y. 2005. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201:1061.
38. Ziegler, S. F. 2006. FOXP3: Of mice and men. Annu. Rev. Immunol. 24:209.
39. Pasare, C. and Medzhitov, R. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033.
40. Korn, T., Bettelli, E., Gao, W. et al. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484.
41. Veldhoen, M., Hocking, R. J., Flavell, R. A. and Stockinger, B. 2006. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7:1151.
42. Okuda, Y., Sakoda, S., Bernard, C. C. et al. 1998. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10:703.
43. Korn, T., Mitsdoerffer, M., Croxford, A. L. et al. 2008. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl Acad. Sci. USA 105:18460.
44. Mathur, A. N., Chang, H. C., Zisoulis, D. G. et al. 2007. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J. Immunol. 178:4901.
45. Li, M. O., Wan, Y. Y. and Flavell, R. A. 2007. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579.
46. Jaensson, E., Uronen-Hansson, H., Pabst, O. et al. 2008. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J. Exp. Med. 205:2139.
47. Coombes, J. L., Siddiqui, K. R., Arancibia-Carcamo, C. V. et al. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204:1757.
48. Mucida, D., Park, Y., Kim, G. et al. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256.
49. Xiao, S., Jin, H., Korn, T. et al. 2008. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181:2277.
50. Brustle, A., Heink, S., Huber, M. et al. 2007. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8:958.
51. Huber, M., Brustle, A., Reinhard, K. et al. 2008. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl Acad. Sci. USA 105:20846.
52. Hill, J. A., Hall, J. A., Sun, C. M. et al. 2008. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 29:758.
53. Laurence, A., Tato, C. M., Davidson, T. S. et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26:371.
54. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C. and Horak, I. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
55. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. and Rudensky, A. Y. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6:1142.
56. Zhou, L., Lopes, J. E., Chong, M. M. et al. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453:236.
57. Ivanov, I. I., Frutos Rde, L., Manel, N., Yoshinaga, K. et al. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337.
58. Kaplan, M. H. and Grusby, M. J. 1998. Regulation of T helper cell differentiation by STAT molecules. J. Leukoc. Biol. 64:2.
59. Nurieva, R., Yang, X. O., Martinez, G. et al. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448:480.
60. Zhou, L., Ivanov, I. I., Spolski, R., Min, R. et al. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:967.
61. Chen, Z., Tato, C. M., Muul, L., Laurence, A. and O'Shea, J. J. 2007. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum. 56:2936.
62. Coquet, J. M., Chakravarti, S., Smyth, M. J. and Godfrey, D. I. 2008. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180:7097.
63. Spolski, R., Kashyap, M., Robinson, C., Yu, Z. and Leonard, W. J. 2008. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc. Natl Acad. Sci. USA 105:14028.
64. Pflanz, S., Timans, J. C., Cheung, J. et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16:779.
65. Takeda, A., Hamano, S., Yamanaka, A. et al. 2003. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170:4886.
66. Villarino, A., Hibbert, L., Lieberman, L. et al. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19:645.
67. Rosas, L. E., Satoskar, A. A., Roth, K. M. et al. 2006. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology. Am. J. Pathol. 168:158.
68. Holscher, C., Holscher, A., Ruckerl, D. et al. 2005. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 174:3534.
69. Batten, M., Li, J., Yi, S. et al. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7:929.
70. Stumhofer, J. S., Laurence, A., Wilson, E. H. et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7:937.
71. Awasthi, A., Carrier, Y., Peron, J. P. et al. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8:1380.
72. Stumhofer, J. S., Silver, J. S., Laurence, A. et al. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8:1363.
73. Fitzgerald, D. C., Zhang, G. X., El-Behi, M. et al. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8:1372.
74. Shinohara, M. L., Kim, J. H., Garcia, V. A. and Cantor, H. 2008. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: Role of intracellular osteopontin. Immunity 29:68.
75. Murugaiyan, G., Mittal, A. and Weiner, H. L. 2008. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J. Immunol. 181:7480.
76. Park, I. K., Shultz, L. D., Letterio, J. J. and Gorham, J. D. 2005. TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1. J. Immunol. 175:5666.
77. Gorelik, L., Fields, P. E. and Flavell, R. A. 2000. Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 165:4773.
78. Harris, T. J., Grosso, J. F., Yen, H. R. et al. 2007. Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J. Immunol. 179:4313.
79. Liu, X., Lee, Y. S., Yu, C. R. and Egwuagu, C. E. 2008. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J. Immunol. 180:6070.
80. Chen, Z., Laurence, A., Kanno, Y. et al. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl Acad. Sci. USA 103:8137.
81. Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E. et al. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121.
82. Zhang, F., Meng, G. and Strober, W. 2008. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9:1297.
83. Yang, X. O., Pappu, B. P., Nurieva, R. et al. 2008. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28:29.
84. Nurieva, R. I., Chung, Y., Hwang, D. et al. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29:138.
85. Bauquet, A. T., Jin, H., Paterson, A. M. et al. 2008. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and T(H)-17 cells. Nat. Immunol. 10:167.
86. Tzartos, J. S., Friese, M. A., Craner, M. J. et al. 2008. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172:146.
87. Kebir, H., Kreymborg, K., Ifergan, I. et al. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13:1173.
88. Duerr, R. H., Taylor, K. D., Brant, S. R. et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461.
89. Fujino, S., Andoh, A., Bamba, S. et al. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65.
90. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. and Sallusto, F. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942.
91. Wilson, N. J., Boniface, K., Chan, J. R. et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8:950.
92. Manel, N., Unutmaz, D. and Littman, D. R. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9:641.
93. Yang, L., Anderson, D. E., Baecher-Allan, C. et al. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454:350.
94. Annunziato, F., Cosmi, L., Santarlasci, V. et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204:1849.
95. Annunziato, F., Cosmi, L., Liotta, F., Maggi, E. and Romagnani, S. 2008. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int. Immunol. 20:1361.
96. Zaba, L. C., Cardinale, I., Gilleaudeau, P. et al. 2007. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204:3183.
97. Sato, K., Suematsu, A., Okamoto, K. et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203:2673.
98. Komiyama, Y., Nakae, S., Matsuki, T. et al. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177:566.
99. Nakae, S., Nambu, A., Sudo, K. and Iwakura, Y. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171:6173.
100. Hofstetter, H. H., Ibrahim, S. M., Koczan, D. et al. 2005. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237:123.
101. Ogura, H., Murakami, M., Okuyama, Y. et al. 2008. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29:628.
102. Kishimoto, T. 2005. Interleukin-6: From basic science to medicine-40 years in immunology. Annu. Rev. Immunol. 23:1.
103. Aujla, S. J., Dubin, P. J. and Kolls, J. K. 2007. Th17 cells and mucosal host defense. Semin. Immunol. 19:377.
104. Rudner, X. L., Happel, K. I., Young, E. A. and Shellito, J. E. 2007. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun. 75:3055.
105. Aujla, S. J., Chan, Y. R., Zheng, M. et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275.
106. Khader, S. A. and Cooper, A. M. 2008. IL-23 and IL-17 in tuberculosis. Cytokine 41:79.
107. Lockhart, E., Green, A. M. and Flynn, J. L. 2006. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177:4662.
108. Khader, S. A., Bell, G. K., Pearl, J. E. et al. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369.
109. Codolo, G., Amedei, A., Steere, A. C. et al. 2008. Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Arthritis Rheum. 58:3609.
110. Milner, J. D., Brenchley, J. M., Laurence, A. et al. 2008. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773.